Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 21 Jun 2024

EGFR kinase domain duplication in lung adenocarcinoma with systemic and intracranial response to a double-dose of furmonertinib: a case report and literature review

in Thoracic Oncology

Hong Lin
Zhengyuan Yang
Zhifeng Li
Junwei Chen
Hongbiao Wang
Yingcheng Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1321587

2,293 views
2 citations

Original Research

Published on 20 Jun 2024

Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer

in Thoracic Oncology

Han Qiao
Yan Feng
Xiaolei Han
Huaping Tang

Frontiers in Oncology

doi 10.3389/fonc.2024.1393684

1,727 views
1 citation

Mini Review

Published on 18 Jun 2024

Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer

in Thoracic Oncology

Hongyan Li
Lina Xu
Hongshun Cao
Tianyi Wang
Siwen Yang
Yixin Tong
Linlin Wang
Qiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1405380

4,971 views
12 citations

Original Research

Published on 18 Jun 2024

Causal association of circulating cytokines with the risk of lung cancer: a Mendelian randomization study

in Thoracic Oncology

Dachen Luo
Zonglian Gong
Qingyuan Zhan
Shan Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1373380

3,352 views
3 citations

Case Report

Published on 18 Jun 2024

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

in Thoracic Oncology

Yanzhu Qin
Shuaiji Lu
Jingwen Chen
Jing Peng
Jijun Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1415748

2,644 views
3 citations

Original Research

Published on 17 Jun 2024

CT radiomics to differentiate neuroendocrine neoplasm from adenocarcinoma in patients with a peripheral solid pulmonary nodule: a multicenter study

in Thoracic Oncology

Xiaoyu Liu
Hongjian Li
Shengping Wang
Shan Yang
Guobin Zhang
Yonghua Xu
Hanfeng Yang
Fei Shan

Frontiers in Oncology

doi 10.3389/fonc.2024.1420213

2,024 views
3 citations

Case Report

Published on 17 Jun 2024

Gastrointestinal stromal tumor with small cell carcinoma infiltration: a case report

in Thoracic Oncology

Yitong Zhou
Liyuan Song
Li Lyu
Shengjie Li
Qimin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1389975

1,549 views

Systematic Review

Published on 11 Jun 2024

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

in Thoracic Oncology

Yutaka Fujiwara
Kazuhiro Shimomura
Teppei Yamaguchi
Junichi Shimizu
Naohiro Watanabe
Reiko Matsuzawa
Kenta Murotani
Yoshitsugu Horio

Frontiers in Oncology

doi 10.3389/fonc.2024.1419256

4,999 views
6 citations

Review

Published on 11 Jun 2024

The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation

in Thoracic Oncology

Xiuyue Man
Xueru Sun
Chen Chen
Yan Xiang
Jing Zhang
Lei Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1367204

4,671 views
5 citations

Editorial

Published on 07 Jun 2024

Editorial: Real-world data and real-world evidence in lung cancer

in Thoracic Oncology

Valerio Gristina
Chukwuka Eze

Frontiers in Oncology

doi 10.3389/fonc.2024.1436077

2,482 views
6 citations

Review

Published on 06 Jun 2024

Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma

in Thoracic Oncology

Haitao Wei
Sa Zhang
Xiaojin Lin
Ruirui Fang
Li Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1411672

2,334 views

Case Report

Published on 06 Jun 2024

A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review

in Thoracic Oncology

Cong Yin
Zheng-jia Liu
Chao He
Hai-xiang Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399868

2,792 views
4 citations

Case Report

Published on 06 Jun 2024

Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance

in Thoracic Oncology

Wanming He
Lihua Tong
Wen Yang
Yanling Yuan
Yu Li
Wubing Tang

Frontiers in Oncology

doi 10.3389/fonc.2024.1298389

2,985 views
3 citations

Original Research

Published on 04 Jun 2024

SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization

in Thoracic Oncology

Guocai Mao
Jing Li
Nan Wang
Hongbin Yu
Shiyu Han
Mengqi Xiang
Huachuan Zhang
Daxiong Zeng
Junhong Jiang
Haitao Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1392417

4,701 views
9 citations

Original Research

Published on 03 Jun 2024

Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma

in Thoracic Oncology

Meng Xiao
Lili Tu
Ting Zhou
Ye He
Xiaohui Li
Qiunan Zuo

Frontiers in Oncology

doi 10.3389/fonc.2024.1396439

1,991 views

Systematic Review

Published on 03 Jun 2024

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Thoracic Oncology

Yuxiang Liang
Haidi Xu
Futao Liu
Lei Li
ChenXi Lin
Yaozhong Zhang
Na Wang
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1281645

4,032 views
11 citations

Case Report

Published on 31 May 2024

Computed tomography guided electromagnetic navigation system in percutaneous laser ablation for treating primary lung cancer: a case report

in Thoracic Oncology

Xiaodan Liu
Shusen Zhang
Honglin Li
Xuezhu Ren
Xiaolan Xu
Xuejing Wang
Liyun Ye
Zhigang Cai

Frontiers in Oncology

doi 10.3389/fonc.2024.1396452

2,486 views
2 citations

Original Research

Published on 31 May 2024

Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis

in Thoracic Oncology

Ella A. Eklund
Ali Mourad
Clotilde Wiel
Sama I. Sayin
Henrik Fagman
Andreas Hallqvist
Volkan I. Sayin

Frontiers in Oncology

doi 10.3389/fonc.2024.1396285

2,925 views
6 citations

Original Research

Published on 24 May 2024

Weighted gene co-expression network analysis and whole genome sequencing identify potential lung cancer biomarkers

in Thoracic Oncology

Mireguli Abudereheman
Zhengjun Lian
Baidurula Ainitu

Frontiers in Oncology

doi 10.3389/fonc.2024.1355527

3,444 views
7 citations

Review

Published on 23 May 2024

Resistance to KRAS inhibition in advanced non-small cell lung cancer

in Thoracic Oncology

Katherina Bernadette Sreter
Maria Joana Catarata
Maximilian von Laffert
Armin Frille

Frontiers in Oncology

doi 10.3389/fonc.2024.1357898

8,151 views
6 citations

Review

Published on 22 May 2024

Multidimensional biological characteristics of ground glass nodules

in Thoracic Oncology

Furong Chen
Jiangtao Li
Lei Li
Lunbing Tong
Gang Wang
Xuelin Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1380527

4,909 views
3 citations

Original Research

Published on 22 May 2024

Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases

in Thoracic Oncology

Jing Li
Xiaofang Zhang
Ye Wang
Yi Jin
Yingqiu Song
Tianlu Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1400792

2,193 views
3 citations

Editorial

Published on 21 May 2024

Editorial: Advances in bronchoscopic techniques for the diagnosis of lung cancer

in Thoracic Oncology

Martina Ferioli
Micaela Romagnoli
Piero Candoli

Frontiers in Oncology

doi 10.3389/fonc.2024.1428006

1,341 views

Original Research

Published on 21 May 2024

Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib

in Thoracic Oncology

Huixian Zhang
Ziheng Zhang
Ningning Yan
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1405683

2,558 views
1 citation

1,976 articles

articles

EGFR kinase domain duplication in lung adenocarcinoma with systemic and intracranial response to a double-dose of furmonertinib: a case report and literature review

Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer

Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer

Causal association of circulating cytokines with the risk of lung cancer: a Mendelian randomization study

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

CT radiomics to differentiate neuroendocrine neoplasm from adenocarcinoma in patients with a peripheral solid pulmonary nodule: a multicenter study

Gastrointestinal stromal tumor with small cell carcinoma infiltration: a case report

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation

Editorial: Real-world data and real-world evidence in lung cancer

Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma

A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review

Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance

SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization

Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Computed tomography guided electromagnetic navigation system in percutaneous laser ablation for treating primary lung cancer: a case report

Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis

Weighted gene co-expression network analysis and whole genome sequencing identify potential lung cancer biomarkers

Resistance to KRAS inhibition in advanced non-small cell lung cancer

Multidimensional biological characteristics of ground glass nodules

Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases

Editorial: Advances in bronchoscopic techniques for the diagnosis of lung cancer

Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib